• Skip to main content

TopShelfMushrooms.com

  • Home
  • About
  • Functional Mushroom Library
  • Mushroom Guides
  • Supplement Reviews

Functional Mushroom Blend Names: How to Find Each Species and Dose

posted on September 28, 2026

By TopShelfMushrooms.com Editorial Team

The short answer: the name on the front of a blend, such as “Focus Blend” or “Daily Defense,” is branding. The species list and amounts are on the Supplement Facts panel. Under U.S. label rules, that panel must list the species in a blend in weight order, but it can give only one total weight for all of them. So you can usually find each species, but often not each species’ dose. The audit sheet below shows what you can work out from a label, what stays unknown, and what to ask the maker.

What a blend name does and does not tell you

Federal labeling rules let a group of ingredients appear under “Proprietary Blend” or another appropriately descriptive term or fanciful name (21 CFR 101.36(c)). A catchy name is therefore allowed, but it is not a specification. It does not say which species are inside, how much of each is there, or which part of the mushroom was used.

The rule that decides what you can find

The panel format is set out in 21 CFR 101.36. For a blend, four points matter to a reader:

  • Ingredients inside the blend must be listed in descending order of predominance by weight.
  • The blend gets one quantity, which is the total weight of the listed ingredients inside it.
  • For these ingredients, the blend paragraph asks for the weight order and the blend total. It does not ask for a separate amount for each one.
  • Vitamins and minerals with established Daily Values are the exception. If they sit inside a blend, they are declared separately with their own amounts.

For other ingredients, the section requires the common or usual name. It does not list a Latin name as required, so a scientific name on a label is a helpful extra rather than a guarantee.

The blend audit sheet

Use one sheet per product. Write “not stated” wherever the label is silent. The list of blanks is the most useful result.

  1. Blend name and total weight. Copy the blend name, the total weight per serving, the serving size (for example, capsules or gummies), and servings per container.
  2. Species in printed order. Write each ingredient exactly as printed, first to last. Order reflects weight rank, not amount.
  3. Do the bounds math. Divide the blend total by the number of ingredients in the weight-ordered list to get the average share. Because the list runs from heaviest to lightest, the first-listed ingredient is at least the average and the last-listed is no more than the average. For example, a 500 mg blend with five listed ingredients averages 100 mg. The first-listed ingredient is at least 100 mg, and the last-listed is at most 100 mg. This is arithmetic from the ordering rule, not data from the label, and it leaves out any vitamins or minerals listed separately. It shows how little the label pins down.
  4. Check the names. Record whether each entry has a common name, a Latin name, or both. Look for the same species listed twice under two different names, which would make the real species count lower than it looks.
  5. Record the material. Note whether the label says fruiting body, mycelium, a mix, powder, or extract. If it does not say, write “not stated.” The National Cancer Institute’s summary says reishi products made from mycelium grown on grain contain large amounts of alpha-glucans from the grain, unlike fruiting bodies and their extracts, which it describes as entirely beta-glucan. That statement is about one genus, so treat it as a reason to ask, not a rule for every species.
  6. Check what the amount refers to. The rule says the amount declared is the weight of the ingredient listed, not of its source. For an extract with the solvent removed, that is the weight of the dried extract. A ratio such as “10:1” is the maker’s statement about starting material. That section of the rule does not ask for it, so ask how it was measured.
  7. Look for constituent amounts. The rule allows a maker to list constituents of an ingredient with their amounts. Note whether any appear and whether the label says how they were tested.
  8. Write down the gaps. Missing per-species amounts, material, and testing details are your questions for the maker.

Latin names: what to expect and where names differ

Scientific names are useful because common names are used loosely. These pairings appear in the sources reviewed for this article:

  • Lion’s mane: Hericium erinaceus
  • Reishi: Ganoderma lucidum is the name most research uses. The National Cancer Institute’s summary explains that the Chinese Pharmacopoeia lists Ganoderma lucidum and Ganoderma sinense as official species, and that Ganoderma lingzhi is another commonly encountered species. It also says molecular studies show the European species originally named G. lucidum is not identical to the East Asian medicinal species, which now has the accepted name Ganoderma sichuanense. A label that says only “reishi” may not settle which species is meant.
  • Turkey tail: Trametes versicolor, also known as Coriolus versicolor. The same summary says many other Trametes species exist and some are hard to tell apart from turkey tail without special testing.
  • Shiitake: the National Cancer Institute writes Lentinus edodes. You will also see Lentinula edodes in other sources. Check a current fungal name database before treating either spelling as settled.
  • Maitake: Grifola frondosa

For anything not listed here, such as chaga, cordyceps, or tremella, look for a species name on the label and confirm it in a mycology or botany reference before relying on it. A bare common name is a reason to ask the maker which species is inside.

Amount: what you can and cannot compare

There is no established dose for a multi-species blend, and this article does not offer one. Published trials are a poor yardstick for a label because the material and the dose differ from study to study. Two examples, both using Hericium erinaceus:

  • A 2009 double-blind trial in Japan randomized 30 adults aged 50 to 80 with diagnosed mild cognitive impairment. The treatment group took four 250 mg tablets, each containing 96% dry powder, three times a day for 16 weeks. A later paper describes that powder as fruiting body. The first author’s listed affiliation is a mushroom company laboratory.
  • A 2020 pilot double-blind trial randomized 49 adults diagnosed with mild Alzheimer’s disease, and 41 completed it. Participants took three 350 mg capsules a day for 49 weeks. The capsules held mycelia grown to contain a set level of a compound called erinacine A. Several of the authors were salaried by the company that supplied the material.

These studies used different materials, different amounts, different time frames, and different participants, and both enrolled people with diagnosed conditions rather than the general public. The 2020 paper describes hericenones as isolated from the fruiting body and erinacines from the mycelium, so the two materials are not simply interchangeable. This article does not report either study’s outcomes and does not suggest either amount for anyone. The point is that “lion’s mane” on a label does not tell you which form, if either, you are getting. A blend with no per-species amount, no stated material, and no constituent information cannot be lined up against either study.

What is known and what is uncertain

    • Known: the label rule lets a blend disclose species in weight order with a single total. The National Cancer Institute says dietary supplements do not need FDA premarket approval unless disease prevention or treatment claims are made, and that the FDA has not approved medicinal mushrooms as a treatment for cancer or any other medical condition.
    • Uncertain: how much of each species a given blend contains, which species a broad common name refers to, and whether an ingredient matches the material used in any study. The same National Cancer Institute summary says ingredients in supplements can vary considerably from lot to lot, with no guarantee that labeled ingredients are present in the stated amounts.
  • Not established by this article: a recommended amount, a benefit, or a comparison between products.

Health and safety limits

  • The National Center for Complementary and Integrative Health says “natural” does not necessarily mean “safe,” and uses wild mushrooms as its example: some are safe to eat and others are not.
  • It advises checking for side effects and for interactions with medications before using any dietary supplement, and telling all of your health care providers about every supplement you use.
  • It also cautions against using an unproven product to delay seeing a provider about a health problem.
  • This article is general information, not a diagnosis or treatment advice. If you take medication or have a health condition, talk with a pharmacist or clinician before adding a mushroom product.

The next practical decision

Finish the audit sheet, then decide which blanks matter to you. If the missing information is per-species amounts, the material used, or how a ratio was measured, contact the maker and ask for it in writing. When you compare products, compare them by what each one discloses, and treat unanswered questions as unknowns rather than as reassurance. Before adding any product, review the finished sheet with a pharmacist or clinician, especially if you take medication.

Sources

  • U.S. Code of Federal Regulations, 21 CFR 101.36, Nutrition labeling of dietary supplements (eCFR)
  • National Center for Complementary and Integrative Health, Are You Considering a Complementary Health Approach? (fact sheet, last updated September 2016)
  • National Cancer Institute, Medicinal Mushrooms (PDQ), Health Professional Version (updated November 2024)
  • Mori K, et al. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 2009
  • Li I-C, et al. Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. Frontiers in Aging Neuroscience, 2020

Filed Under: mushrooms

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Top Shelf Mushrooms

An independent editorial publication covering functional mushroom research and education.

Topics

  • Functional Mushroom Library
  • Mushroom Guides

Publication

  • About
  • Research Standards
  • Editorial Standards
  • Contact

Policies

  • Affiliate Disclosure
  • Medical Disclaimer
  • Privacy Policy
  • Terms of Use

About This Site: Top Shelf Mushrooms is an independent editorial publication covering functional mushroom research and education. This site is not a medical practice, clinic, supplement manufacturer, pharmacy, or healthcare provider. No content on this site constitutes medical advice, diagnosis, or treatment recommendation. Always consult a qualified healthcare provider before starting any supplement.

Research Standards: Supplement research discussed on this site relates to ingredients as studied in published scientific literature. In vitro, animal model, and human clinical trial findings are distinguished throughout our content. Ingredient research does not validate specific commercial products.

Paid Links: Some links on this site are paid links. Top Shelf Mushrooms has a commercial relationship with Pilly Labs. If you purchase through links to Pilly Labs products, Top Shelf Mushrooms may benefit commercially at no additional cost to you. This does not influence our research or editorial standards. See our Affiliate Disclosure for full details.

© 2026 Top Shelf Mushrooms · Edited by Sage Mercer